Does Block Play Improve Language Acquisition: A Randomized Trial

This study has been completed.
Sponsor:
Collaborator:
Megablocks
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00428376
First received: January 26, 2007
Last updated: September 25, 2008
Last verified: September 2008
  Purpose

This is a randomized controlled trial of distributing blocks to children ages 1.5 -2.5 years of age to see if language acquisition improves.


Condition Intervention
Healthy
Device: Building Blocks

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind
Official Title: Clinical Trial of Building Block Distribution in Children

Resource links provided by NLM:


Further study details as provided by University of Washington:

Primary Outcome Measures:
  • Macarthur Bates Language Inventory

Secondary Outcome Measures:
  • TV viewing
  • Block play

Estimated Enrollment: 200
Study Start Date: September 2005
Study Completion Date: September 2006
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Children in age group are randomized to get two sets of blocks or not. Outcomes include language development assessed using the Macarthur Bates CDI 6 months after enrollment.

  Eligibility

Ages Eligible for Study:   18 Months to 30 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy children

Exclusion Criteria:

  • developmental delay, non-English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00428376

Sponsors and Collaborators
University of Washington
Megablocks
Investigators
Principal Investigator: Dimitri Christakis, MD MPH University of Washington
  More Information

No publications provided

Responsible Party: Dmitri Christakis, MD, MPH, University of Washington
ClinicalTrials.gov Identifier: NCT00428376     History of Changes
Other Study ID Numbers: 05-0636-01
Study First Received: January 26, 2007
Last Updated: September 25, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on October 21, 2014